merck

When it comes to the search for Ebola treatments, names like BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX), Chimerix Inc (NASDAQ: CMRX), Sarepta Therapeutics Inc (NASDAQ: SRPT) and Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR) have cropped up frequently. Could these or other biotech companies...

U.S. stocks reversed early morning declines and closed the day little changed ahead of Friday's job reports data, which will be released at 8:30 A.M. The number of Americans filing claims for unemployment benefits unexpectedly fell last week by 8,000 according to data released today. Not...

U.S. stocks were little changed with the S&P 500 closing for the second straight day above the 2,000 mark. Markets were on track for a flat open and volume and volatility remained relatively light throughout the trading session as geopolitical events remain in focus. Israel and Gaza have...

U.S. stocks rose, lifting the Dow to new historical all-time highs of 17,153.80 following a better than expected rise in orders of durable goods. Consumer confidence improved in August, helping market sentiments while investors and traders placed less emphasis on a report that home prices are...

U.S. markets managed to squeeze out small gains in lighter than normal volume, as geopolitical tensions may be calming down. Russia President Vladimir Putin said that the country will coordinate with the International Red Cross to send humanitarian aid to Ukraine. Meanwhile, Palestinians and...

U.S. stocks declined and erased Monday's gains following reports that Russian troops were lining on the borders of Ukraine and preparing for an invasion, according to comments made by Poland's Foreign Minister. “Unfortunately, Russia has restored its combat readiness on the...

Merck (NYSE: MRK) is a blue chip "Big Pharma" stock that is up for the last week, month, quarter, six months and year of market action. For 2014, Merck has risen by nearly 19 percent. There are three reasons for long-term investors to buy shares of Merck in expectation that the share...

The earnings crunch continues, and reports so far have generally been encouraging. Among the many quarterly reports scheduled to hit the tape this week are those from Exxon Mobil, Pfizer, Procter & Gamble and Whole Foods, from which analysts expect to see at least marginal earnings gains....

With the American Heart Association and CEOs of more than 20 major companies recently joining to encourage healthy lifestyle choices, stressing good health is important to companies and employees alike. A number of other major corporations, meanwhile, have a history of leadership when it...

U.S. stocks were slightly lower as investors digested a report by Goldman Sachs speculating that the Fed Funds rate may be increased in the third quarter of 2015, earlier than expected. Earnings season unofficially kicks off this week with Alcoa (NYSE: AA) reporting on Tuesday. Many Dow...

U.S. stocks were slightly higher as the Dow and S&P 500 indices continue hitting new all-time highs following positive comments from the Fed's Chief Janet Yellen earlier this week. The Dow continues to flirt with the 17,000 mark and hit a historical intra-day high of 16,978.0 Friday...

ETF Outlook for Tuesday, June 10, 2014 iShares Dow Jones U.S. Regional Banks ETF (NYSE: IAT) The strong sector Monday was the regional banks as they try and catch up to the rest of the market. IAT was up 1.5 percent to the best level since March and is now within striking distance of a six-...

U.S. markets rose for the fourth straight session as investors positively digested comments coming from the St. Louis Fed. Jim Bullard, the St. Louis Fed chief said that inflation is low but moving back toward the two percent target. As such, Bullard argued that the Federal Reserve Open...

While Amgen (NASDAQ: AMGN) saw a sizable dip in short interest between the April 30 and May 15 settlement dates, short sellers piled on Medivation (NASDAQ: MDVN) and Pharmacyclics (NASDAQ: PCYC). Among other leading biotechs and emerging pharmaceuticals, gains in the number of their shares sold...